Vecabrutinib Uses, Dosage, Side Effects and more
Vecabrutinib is under investigation in clinical trial NCT03037645 (Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers).
Trade Name | Vecabrutinib |
Generic | Vecabrutinib |
Type | |
Formula | C22H24ClF4N7O2 |
Weight | Average: 529.92 Monoisotopic: 529.1616134 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |